國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Global health partnershipsthe pharma...

Wang, Mei-Ling, (1960-)

Global health partnershipsthe pharmaceutical industry and BRICA /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Global health partnershipsMei-Ling Wang.
其他題名:	the pharmaceutical industry and BRICA /
作者:	Wang, Mei-Ling,
出版者:	Basingstoke [England] ;Palgrave Macmillan,2009.
面頁冊數:	1 online resource (x, 193 p.)
附註:	Description based on print version record.
標題:	World health.
電子資源:	access to fulltext (Palgrave)
ISBN:	9780230582873 (electronic bk.)

Global health partnershipsthe pharmaceutical industry and BRICA /
Wang, Mei-Ling,1960-

Global health partnershipsthe pharmaceutical industry and BRICA /[electronic resource] :Mei-Ling Wang. - Basingstoke [England] ;Palgrave Macmillan,2009. - 1 online resource (x, 193 p.)

Description based on print version record.

Includes bibliographical references (p. 167-187) and index.

Global health partnerships: an introduction -- Modern pharmaceuticalindustry: history, current position and challenges -- The BRICAs in global pharmaceutical provision -- Global health partnerships between multinationals and the BRICAs: a planting strategy.

The challenges facing multinational pharmaceutical companies have never been greater and the need for an innovative solution has never beenmore urgent. The decrease of profits in pharmaceuticalmarkets in developed countries, the increasing pressure of price controls from regulators, the rapid increase of epidemics, pandemics and chronic illnesses, and a contracted global economy have led to a pessimistic forecast of the pharmaceutical industry in developed countries. On the other hand, the prospects for pharmaceutical development have never been better in BRICAs (Brazil, Russia, India,China and African countries). This book provides a new strategy to resolve the imbalance in global pharmaceutical supply and demand chains by proposing a new global health partnershipmodel between the stakeholders in developed countries and those in BRICAs. This strategy aims to multiply the strengths of all stakeholders and create a sustainable growth scenario that benefits all populations.

ISBN: 9780230582873 (electronic bk.)

Standard No.: 10.1057/9780230582873doiSubjects--Topical Terms:

191506
World health.
Index Terms--Genre/Form:

214472
Electronic books.

LC Class. No.: RA401.A1 / W36 2009eb

Dewey Class. No.: 362.17/82

Global health partnershipsthe pharmaceutical industry and BRICA /
LDR:02477cmm 2200301Ia 4500 001 259364
003 OCoLC
005 20100709081737.0
006 m d
007 cr cnu---unuuu
008 100903s2009 enk sb 001 0 eng d
020 $a 9780230582873 (electronic bk.)
020 $a 0230582877 (electronic bk.)
024 7 $a 10.1057/9780230582873 $2 doi
035 $a (OCoLC)314821483
035 $a ocn314821483
040 $a UKPGM $b eng $c UKPGM $d YDXCP $d N $d EBLCP
049 $a APTA
050 4 $a RA401.A1 $b W36 2009eb
082 0 4 $a 362.17/82 $2 22
100 1 $a Wang, Mei-Ling, $d 1960- $3 459848
245 1 0 $a Global health partnerships $h [electronic resource] : $b the pharmaceutical industry and BRICA / $c Mei-Ling Wang.
260 $a Basingstoke [England] ; $a New York : $b Palgrave Macmillan, $c 2009.
300 $a 1 online resource (x, 193 p.)
500 $a Description based on print version record.
504 $a Includes bibliographical references (p. 167-187) and index.
505 0 $a Global health partnerships: an introduction -- Modern pharmaceuticalindustry: history, current position and challenges -- The BRICAs in global pharmaceutical provision -- Global health partnerships between multinationals and the BRICAs: a planting strategy.
520 $a The challenges facing multinational pharmaceutical companies have never been greater and the need for an innovative solution has never beenmore urgent. The decrease of profits in pharmaceuticalmarkets in developed countries, the increasing pressure of price controls from regulators, the rapid increase of epidemics, pandemics and chronic illnesses, and a contracted global economy have led to a pessimistic forecast of the pharmaceutical industry in developed countries. On the other hand, the prospects for pharmaceutical development have never been better in BRICAs (Brazil, Russia, India,China and African countries). This book provides a new strategy to resolve the imbalance in global pharmaceutical supply and demand chains by proposing a new global health partnershipmodel between the stakeholders in developed countries and those in BRICAs. This strategy aims to multiply the strengths of all stakeholders and create a sustainable growth scenario that benefits all populations.
650 0 $a World health. $3 191506
650 0 $a Public health $x International cooperation. $3 191505
650 0 $a Pharmaceutical industry. $3 188828
650 0 $a Pharmaceutical policy. $3 323280
655 7 $a Electronic books. $2 local. $3 214472
776 0 8 $i Print version: $a Wang, Mei-Ling, 1960- $t Global health partnerships. $d Basingstoke [England] ; New York : Palgrave Macmillan, 2009 $z 9780230515604 $w (DLC) 2008041055 $w (OCoLC)144227166
856 4 0 $3 Palgrave Connect $u http://www.palgraveconnect.com/doifinder/10.1057/9780230582873 $z access to fulltext (Palgrave)